Clinical Trial Update: Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD [Phase 4]

View source ↗

Summary

A phase 4 clinical trial investigating escalating adalimumab for prevention of relapse in inflammatory bowel disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: McMaster University | Conditions: Crohn Disease, Ulcerative Colitis | Phase 4 | Status: WITHDRAWN